中西药物联合抢救脑卒中昏迷42例临床研究  

作　　者：张娴 张应宏 杜平 黄洁 

机构地区：[1]四川省南充市中心医院急诊科,四川南充637000

出　　处：《中国药业》2017年第A01期36-37,共2页China Pharmaceuticals

摘　　要：目的探讨中西药物联合抢救脑卒中昏迷的临床疗效。方法选取2013年9月至2016年7月收治的脑卒中昏迷患者84例,采用随机数字表法分为对照组和治疗组,各42例。对照组常规采用纳洛酮静脉滴注治疗,治疗组在对照组治疗基础上加用醒脑静注射液静脉滴注联合治疗。两组均治疗每日2次,连续治疗2周。结果治疗组的平均昏迷持续与住院时间均显著短于对照组(P<0.05)。治疗组总有效率为92.86%,高于对照组的69.05%(P<0.05);治疗后,两组NIHSS、GCS、生活质量评分均优于治疗前,且治疗组优于对照组(P<0.05)。结论中西药物联合抢救脑卒中昏迷患者疗效显著高于单一西药治疗,具有较好的临床疗效,具有较高的临床应用价值。Objective To discuss clinical curative effect of the Chinese and Western medicine in rescuing stroke coma.Methods From September 2013 to July 2016,84 cases of patients with cerebral stroke coma as in our hospital were selected the research object,using the random number table method,they were divided into control group(n=42)and treatment group(n=42).Control group using conventional naloxone intravenous drip treatment,on the basis of treatment in the control group,treatment group was given Xingnaojing Injection intravenous drip combined treatment,twice a day,for 2 weeks.Results The average coma duration and hospitalization in treatment group were significantly shorter than the control group(P<0.05).The total effective rate in the treatment group was 92.86%,which was higher than 69.05%in the control group(P<0.05).The scores of NIHSS,GCS and quality of life in the two group were significantly better than those before treatment,and those in the treatment group were better than those in the control group(P<0.05).Conclusion Chinese and Western medicine in rescuing stroke coma patients has better curative effect than single Western medicine treatment,it has good clinical curative effect,which has high clinical value.

关 键 词：醒脑静注射液 纳洛酮 脑卒中 昏迷 临床疗效 

分 类 号：R2-031[医药卫生—中西医结合]